The platelet rich plasma, also known as the PRP, is an enhanced source of the plasma that is present in the blood. The platelet rich plasma is widely applicable in the medical field and is also used in treating cosmetic surgeries. The treatment includes the extraction of plasma, which is obtained by the centrifuging the extracted blood from the patient's vein and then again injected in the affected areas. The platelet rich plasma is widely used in tissue healing, bone surgeries followed by the cosmetic treatments that remove the wrinkles and tightens the skin.
The
platelet rich plasma market is growing rapidly with time; according to the result of the study of the platelet rich plasma market report that is available online by DecisionDatabases.com. This market report has also described the reasons supporting this statement, which includes the factors like increasing count of orthopedic diseases, followed by the rise in a number of the sports injuries. However, the factors like developing neurological disorders and demand in cosmetic surgeries has also propelled the platelet rich plasma industry. On the other hand, factor like costly treatments acts as the restraint and retards the growth of this market.
The platelet rich plasma market report has also elaborated the market segments, based on type, origin, application and geography. Based on the type, the platelet rich plasma market is classified as pure platelet rich plasma or P-PRP, leukocyte-rich platelet rich plasma or L-PRP and pure platelet rich fibrin or P-PRF or leukocyte-rich platelet rich fibrin or L-PRF. Among these listed segments, the use of pure platelet rich plasma or P-PRP is very high, as compared to other segments owing to the higher efficiency results. However, on the basis of origin, the market is segmented into autologous platelet rich plasma, allogeneic platelet rich plasma, and homologous platelet rich plasma.
Furthermore, the classification on the basis of application includes orthopedic surgery, cosmetic surgery, general surgery, neurosurgery and other surgeries, including the use of platelet rich plasma in urology, cardiothoracic, oral and maxillofacial treatments followed by the periodontal treatments too. Out of all this, the orthopedic surgeries dominate this market followed by the cosmetic surgeries. Lastly, on the basis of geography, the platelet rich plasma market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa; and North America leads the platelet rich plasma market owing to the wide adoption of advanced technology in numerous treatments.
The report also covers the list of companies ruling this market, followed by their company profiling and company descriptions of each company. The list of major player of the platelet rich plasma market includes EmCyte Corporation, Exactech, Inc., Harvest Technologies Corp., Nuo Therapeutics, Inc., Regen Lab SA, Stryker Corporation, AdiStem Ltd., Arteriocyte Medical Systems, Inc., Arthrex, Inc., Biomet, Inc., Cesca Therapeutics, Inc., DePuy Synthes, Inc., and Dr. PRP America LLC.
About-Us:
DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.
Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.
For more details:
DecisionDatabases.com
E-Mail:
[email protected]
Phone: +91 99 28 237112
Web:
www.decisiondatabases.com/
